A fuzzy physiologically based pharmacokinetic modeling framework to predict drug disposition in humans

To date, the application of physiologically based pharmacokinetic (PBPK) models in support of drug discovery remains limited, in part due to information deficit and uncertainty regarding model parameters. Fuzzy set theory provides a suitable way to objectively account for parameter uncertainty in models. Here, we present a fuzzy set-based PBPK modeling framework and demonstrate its utility in predicting diazepam pharmacokinetics in human plasma, following intravenous dosing, from available animal in vivo and literature data. For computationally expensive PBPK models, the sparse grid method is proposed as an efficient alternative to commonly used fuzzy arithmetic algorithms for function simulation.

[1]  T. Ross Fuzzy Logic with Engineering Applications , 1994 .

[2]  K H Antonin,et al.  Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. , 1976, The Journal of pharmacology and experimental therapeutics.

[3]  G. E. Searle,et al.  APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA , 2006, Drug Metabolism and Disposition.

[4]  Barbara I. Wohlmuth,et al.  Algorithm 847: Spinterp: piecewise multilinear hierarchical sparse grid interpolation in MATLAB , 2005, TOMS.

[5]  I. Nestorov,et al.  Modelling and simulation of variability and uncertainty in toxicokinetics and pharmacokinetics. , 2001, Toxicology letters.

[6]  G. Searle,et al.  APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN HUMAN PLASMA , 2006, Drug Metabolism and Disposition.

[7]  Yuichi Sugiyama,et al.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals , 1984, Journal of Pharmacokinetics and Biopharmaceutics.

[8]  Malcolm Rowland,et al.  Fuzzy Simulation of Pharmacokinetic Models: Case Study of Whole Body Physiologically Based Model of Diazepam , 2004, Journal of Pharmacokinetics and Pharmacodynamics.

[9]  W. Dong,et al.  Vertex method for computing functions of fuzzy variables , 1987 .

[10]  H. Trussell,et al.  Constructing membership functions using statistical data , 1986 .

[11]  Patrick Poulin,et al.  Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection. , 2003, Toxicology letters.

[12]  G. Grass,et al.  Physiologically-based pharmacokinetic simulation modelling. , 2002, Advanced drug delivery reviews.

[13]  S. Stefánsson,et al.  Electroencephalographic effects and serum concentrations after intranasal and intravenous administration of diazepam to healthy volunteers. , 2001, British journal of clinical pharmacology.

[14]  G. Grass Physiologically-based pharmacokinetic simulation modeling , 2002 .

[15]  Yuichi Sugiyama,et al.  Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model , 1983, Journal of Pharmacokinetics and Biopharmaceutics.

[16]  I. Turksen Measurement of membership functions and their acquisition , 1991 .

[17]  Michael Hanss,et al.  Applied Fuzzy Arithmetic , 2005 .

[18]  J. D. Jones,et al.  Calculating functions of fuzzy numbers , 1993 .